Effect of Radiofrequency in Women With Chronic Pelvic Pain With an Associated Myofascial Syndrome Versus Myofascial Therapy and no Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorHospital Clinic of Barcelona

About this trial

A randomised clinical trial is being conducted in the Gynecology Department of the Hospital Clinic de Barcelona in women presenting chronic pelvic pain syndrome due to a myofascial cause which is over a 4 score in the VAS scale and not related to an obstetric injury. This study presents 4 groups; two groups receive 8 radiofrequency sessions, one group receives 8 sessions of myofascial release therapy (MRT) and the last group receives no treatment at all (NT). The two RF groups have been divided into a RF intervention group (RFIG) and a RF control group (RFCG) which receives sham treatment. The RF groups are double-blinded. Other than RF, both groups perform daily Thiele massage at home. The sessions last for 20 minutes and take place once a week during 8 weeks.

The main variable evaluated is the level of pain during the muscular assessment carried out by an expert pelvic floor physical therapist using the Verbal numeric Scale in the first session and at the end of the 8 sessions. Secondary variables are: sexual function (throughout FSFI questionnaire), pain catastrophizing (ECD), quality of life (EQ5D), anxiety and depression (HADS), central sensitization (CSI) as well as other pelvic floor dysfunction symptoms (PFDI).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

At least 18 years of age

Presenting with pelvic pain persisting for at least 6 months

Diagnosed with myofascial syndrome of the pelvic floor muscles (PFM) by a specialist based on physical assessment

Presenting with pelvic pain intensity greater than 4 on the Visual Analog Scale (VAS) in the last 3 months

Disqualifiers

Patients who were pregnant

Postpartum patients who had given birth within the last year

Patients with a history of vulvovaginal pathology

Contraindications for the use of radiofrequency: metal implants or active infection

Trial design

Design model

Parallel

Treatments tested in this trial

  • Radiofrequency therapy

    Device

    Radiofrequency or myofascial manual therapy sessions including the abdominal region, the vulva and pelvic floor tissue and Thiele massage done daily by the patient at home

  • myofascial manual therapy

    Other intervention

    Myofascial manual therapy sessions including the abdominal region, the vulva and pelvic floor tissue and Thiele massage done daily by the patient at home

Treatment groups

80 Participants
are divided into 4 treatment groups
Group A: ON RFActive comparator 1 intervention
Group B: OFF RFSham comparator 1 intervention
Group C: MYOFASCIAL MANUAL THERAPYActive comparator 1 intervention
Group D: NO TREATMENTNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Pain Level

Pain Level using the Verbal Numeric Scale (VNS). The scores go from 0 (lowest) to 10 (highest)

Time frame
8 weeks

Secondary outcomes

1

Sexual function

Sexual function using the female sexual function index. The score ranges from 2 (severe) to 36 (no sexual disfunction)

Time frame
8 weeks
2

Quality of life (QoL)

Quality of life using the EuroQuality of life-5Dimensions (EQ5D. Ranges from -0.59 (lowest QoL) and 1 (highest)

Time frame
8 weeks
3

Pain catastrophizing

Using the pain catastrophizing scale (PCS).Ranges from 0 to 52 where higher scores indicate a greater degree of pain catastrophizing. A total score of \>30 represents a clinically significant level of pain catastrophization

Time frame
8 weeks
4

Anxiety and depression

Anxiety and depression using the Hospital Anxiety and depression Scale (HADS). Generally, scores of 0 to 7 on this questionnaire are considered to be normal, scores of 8 to 10 indicate mild symptoms, 11 to 14 indicate moderate symptoms, and 15 to 21 indicate severe symptoms

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.